The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer

Abstract

Aberrant activation of the PI3K/Akt pathway commonly occurs in cancers and correlates with multiple aspects of malignant progression. In particular, recent evidence suggests that the PI3K/Akt signaling plays a fundamental role in promoting the so-called aerobic glycolysis or Warburg effect, by phosphorylating different nutrient transporters and metabolic enzymes, such as GLUT1, HK2, PFKB3/4 and PKM2, and by regulating various molecular networks and proteins, including mTORC1, GSK3, FOXO transcription factors, MYC and HIF-1α. This leads to a profound reprogramming of cancer metabolism, also impacting on pentose phosphate pathway, mitochondrial oxidative phosphorylation, de novo lipid synthesis and redox homeostasis and thereby allowing the fulfillment of both the catabolic and anabolic demands of tumor cells. The present review discusses the interactions between the PI3K/Akt cascade and its metabolic targets, focusing on their possible therapeutic implications.

References 172

1. 1.

   The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions. Exp Mol Pathol [Internet]. 2022;127:104787.

   Not in our library10.1016/j.yexmp.2022.104787

2. 2.

   The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer [Internet]. 2020;20:74-88.

   Not in our library10.1038/s41568-019-0216-7

3. 3.
   Targeting PI3K in cancer: mechanisms and advances in clinical trials · 2019

   No notice
4. 4.

   PI3K pathway alterations in cancer: variations on a theme. Oncogene [Internet]. 2008;27:5497-510.

   Not in our library10.1038/onc.2008.245

5. 5.

   Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery. Nat Rev Drug Discov [Internet]. 2005;4:988-1004.

   Not in our library10.1038/nrd1902

6. 6.

   PI3K-PKB/Akt Pathway. Cold Spring Harb Perspect Biol [Internet]. 2012;4:a011189-a011189.

   Not in our library10.1101/cshperspect.a011189

7. 7.

   A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. Cancer Cell [Internet]. 2017;31:820-832.e3.

   Not in our library10.1016/j.ccell.2017.04.013

8. 8.
   Akt: a key transducer in cancer · 2022

   Not checked
9. 9.

   Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science (80- ) [Internet]. 2009;324:1029-33.

   Not in our library10.1126/science.1160809

10. 10.

    The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci [Internet]. 2016;41:211-8.

    Not in our library10.1016/j.tibs.2015.12.001

11. 11.

    The Warburg effect: Evolving interpretations of an established concept. Free Radic Biol Med [Internet]. 2015;79:253-63.

    Not in our library10.1016/j.freeradbiomed.2014.08.027

12. 12.

    Molecular Crowding Defines a Common Origin for the Warburg Effect in Proliferating Cells and the Lactate Threshold in Muscle Physiology. Moreno Y, Ed. PLoS One [Internet]. 2011;6:e19538.

    Not in our library10.1371/journal.pone.0019538

13. 13.

    Glucose transporters in cancer - from tumor cells to the tumor microenvironment. FEBS J [Internet]. 2018;285:2926-43.

    Not in our library10.1111/febs.14577

14. 14.

    Expression of metabolically targeted biomarkers in endometrial carcinoma. Gynecol Oncol [Internet]. 2010;116:21-7.

    Not in our library10.1016/j.ygyno.2009.10.040

15. 15.

    Recurrent prognostic factors and expression of GLUT-1, PI3K and p-Akt in adenoid cystic carcinomas of the head and neck: Clinicopathological features and biomarkers of adenoid cystic carcinoma. Oncol Lett [Internet]. 2012;4:1234-40.

    Not in our library10.3892/ol.2012.895

16. 16.

    Expression of Glut-1, HIF-1α, PI3K and p-Akt in a case of ceruminous adenoma. Head Neck Oncol [Internet]. 2012;4:18.

    Not in our library10.1186/1758-3284-4-18

17. 17.

    Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. Cell Signal [Internet]. 2016;28:377-83.

    Not in our library10.1016/j.cellsig.2016.01.011

18. 18.

    Roles of glucose transporter-1 and the phosphatidylinositol 3-kinase/protein kinase B pathway in cancer radioresistance (Review). Mol Med Rep [Internet]. 2015;11:1573-81.

    Not in our library10.3892/mmr.2014.2888

19. 19.

    Identification of novel inhibitors of GLUT1 by virtual screening and cell-based assays. Invest New Drugs [Internet]. 2021;39:1242-55.

    Not in our library10.1007/s10637-021-01109-2

20. 20.

    Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy. Front Pharmacol [Internet]. 2022; 13. Available at: https://www.frontiersin.org/articles/10.3389/fphar. 2022.

    Not in our library10.3389/fphar.2022.1035882

21. 21.

    Hexokinases in cancer and other pathologies. Cell Insight [Internet]. 2023;2:100077.

    Not in our library10.1016/j.cellin.2023.100077

22. 22.
    Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters · 2021

    No notice
23. 23.

    FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway. Exp Cell Res [Internet]. 2021;398:112401.

    Not in our library10.1016/j.yexcr.2020.112401

24. 24.

    CPNE1 Enhances Colorectal Cancer Cell Growth, Glycolysis, and Drug Resistance Through Regulating the AKT-GLUT1/HK2 Pathway. Onco Targets Ther [Internet]. 2021.

    Not in our library10.2147/ott.s284211

25. 25.

    SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells. Shi X, Ed. PLoS One [Internet]. 2015;10:e0129834.

    Not in our library10.1371/journal.pone.0129834

26. 26.

    Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells. J Ovarian Res [Internet]. 2022;15:92.

    Not in our library10.1186/s13048-022-01027-8

27. 27.

    Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through Akt1/p-Akt1 in cervical cancer cells. Cancer Cell Int [Internet]. 2021;21:600.

    Not in our library10.1186/s12935-021-02312-0

28. 28.

    ROCK2 Promotes Osteosarcoma Growth and Glycolysis by Up-Regulating HKII via Phospho-PI3K/AKT Signalling. Cancer Manag Res [Internet]. 2021.

    Not in our library10.2147/cmar.s279496

29. 29.

    TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2. Gene [Internet]. 2020;747:144553.

    Not in our library10.1016/j.gene.2020.144553

30. 30.

    Hexokinases <scp>II</scp> -mediated glycolysis governs susceptibility to crizotinib in <scp>ALK</scp> -positive non-small cell lung cancer. Thorac Cancer [Internet]. 2021;12:3184-93.

    Not in our library10.1111/1759-7714.14184

31. 31.

    Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis. J Biol Chem [Internet]. 2002;277:7610-8.

    Not in our library10.1074/jbc.m109950200

32. 32.

    Hexokinase-Mitochondria Interaction Mediated by Akt Is Required to Inhibit Apoptosis in the Presence or Absence of Bax and Bak. Mol Cell [Internet]. 2004;16:819-30.

    Not in our library10.1016/j.molcel.2004.11.014

33. 33.

    Akt Inhibits Apoptosis Downstream of BID Cleavage via a Glucose-Dependent Mechanism Involving Mitochondrial Hexokinases. Mol Cell Biol [Internet]. 2004;24:730-40.

    Not in our library10.1128/mcb.24.2.730-740.2004

34. 34.

    PHLPP regulates hexokinase 2-dependent glucose metabolism in colon cancer cells. Cell Death Discov [Internet]. 2017;3:16103.

    Not in our library10.1038/cddiscovery.2016.103

35. 35.

    PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling. Annu Rev Pharmacol Toxicol [Internet]. 2021;61:723-43.

    Not in our library10.1146/annurev-pharmtox-031820-122108

36. 36.

    Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca 2+ -dependent death of cancer cells. EMBO Rep [Internet]. 2020.

    Not in our library10.15252/embr.201949117

37. 37.

    Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc Natl Acad Sci [Internet]. 2012;109:20491-6.

    Not in our library10.1073/pnas.1206530109

38. 38.

    Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med [Internet]. 2011;208:313-26.

    Not in our library10.1084/jem.20101470

39. 39.

    Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer. Cancer Cell [Internet]. 2013;24:213-28.

    Not in our library10.1016/j.ccr.2013.06.014

40. 40.

    Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis. Coleman WB, Ed. PLoS One [Internet]. 2016;11:e0166230.

    Not in our library10.1371/journal.pone.0166230

Cited by papers we hold 1

• Mitochondrial metabolism and cancer therapeutic innovation · 2025
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.